SIMONE MARTIN: Open Payments
NPI 1558709832 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 29 payments from 7 companies in 2025. Trend: 2023 $371 · 2024 $296 · 2025 $454
Food & beverage: $386Education: $68
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 20 | $233 |
| Janssen Biotech, Inc. | 2 | $87 |
| UROGEN PHARMA, INC. | 2 | $48 |
| COLOPLAST CORP | 2 | $30 |
| Laborie Medical Technologies Corp. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Boston Scientific Corporation | 1 | $18 |
Products named: ORGOVYX, ERLEADA, GEMTESA, Luja Coude, JELMYTO, ZUSDURI, BOTOX, SpaceOAR VUE System - 10mL.
Industry payments across NE — which companies pay providers there.
